Month: November 2020

CMS Approves Coverage of COVID Antibody Treatment for Medicare Beneficiaries

CMS Approves Coverage of COVID Antibody Treatment for Medicare Beneficiaries

New COVID cases reported daily have more than doubled during recent weeks, since a more modest July surge. As the nation’s COVID-19 pandemic continues to spiral out of control, federal authorities are racing to find ways to mitigate the spread. The Centers for Medicare & Medicaid Services (CMS) announced last week that Medicare beneficiaries will […]
Learn More
Medicare Finalizes COVID-19 Vaccine Payment Amounts

Medicare Finalizes COVID-19 Vaccine Payment Amounts

The government is working at warp speed to make a COVID-19 vaccine available in the United States. To that end, the Centers for Medicare & Medicaid Services (CMS) recently published an interim final rule with comment period (IFC) to implement Section 3713 of the Coronavirus Aid, Relief, and Economic Security Act (CARES Act), which established Medicare Part […]
Learn More
CMS Provides Updated Guidance on Billing For Covid-19 Monoclonal Antibody Treatments

CMS Provides Updated Guidance on Billing For Covid-19 Monoclonal Antibody Treatments

  CMS updated its COVID-19 billing FAQs on October 28 to address billing scenarios for potential monoclonal antibody treatments. The two new FAQs, which appear in section BB. Drugs and Vaccines under Part B, address billing for monoclonal antibody treatments provided in the hospital outpatient setting. CMS notes that if a monoclonal antibody product is granted an […]
Learn More

ICD-10-CM Coding For Autoimmune Hemolytic Anemia

Cold antibody hemolytic anemia is a rare autoimmune disorder characterized by the premature destruction of red blood cells by autoantibodies at temperatures of approximately 0 to 10 degrees Celsius. Q: What is the difference between cold, hot, and mixed type autoimmune hemolytic anemia, as described by 2021 ICD-10-CM codes D59.11-D59.13? A: ICD-10-CM code category D59.- (acquired […]
Learn More
CMS Finalizes Additional Payment for New COVID-19 Treatments

CMS Finalizes Additional Payment for New COVID-19 Treatments

CMS’ Fourth COVID-19 Interim Final Rule with Comment Period (IFC-4) includes additional payment for new COVID-19 treatments, price transparency requirements for COVID-19 diagnostic tests, and coverage for potential vaccines among other provisions. Most provisions of IFC-4 became effective November 2. Hospital Payment for New COVID-19 Treatments The New COVID-19 Treatments Add-on Payment (NCTAP) will provide additional Medicare […]
Learn More
ICD-10-PCS Codes for Treating COVID-19

ICD-10-PCS Codes for Treating COVID-19

The ICD-10-PCS codes can be found in the XW0 Table for the drug infusions. There were new ICD-10-PCS codes implemented on Aug. 1, involving substances associated with the treatment of COVID-19. As we know, these codes are not to be assigned unless the substances were used to treat coronavirus. Here is some information regarding these […]
Learn More
x
Close